CT83 and gastric cancer: It was worth noting that even in patients with stage I gastric cancers, the CT83 expression rate (79.4%) was high, suggesting that CT83 was a potential biomarker for early diagnosis of gastric cancer.29 Additionally, Fukuyama et al30 reported that anti‐H.